These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9358933)

  • 21. A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37.
    Wapnir IL; Aebi S; Geyer CE; Zahrieh D; Gelber RD; Anderson SJ; Robidoux A; Bernhard J; Maibach R; Castiglione-Gertsch M; Coates AS; Piccart MJ; Clemons MJ; Costantino JP; Wolmark N; ; ;
    Clin Breast Cancer; 2008 Jun; 8(3):287-92. PubMed ID: 18650162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. International Breast Cancer Study Group.
    Wallgren A; Bernier J; Gelber RD; Goldhirsch A; Roncadin M; Joseph D; Castiglione-Gertsch M
    Int J Radiat Oncol Biol Phys; 1996 Jul; 35(4):649-59. PubMed ID: 8690630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality-of-life changes over time in breast cancer patients undergoing breast-conserving surgery: a prospective study in Greece.
    Eskitzis P; Zafrakas M; Papanicolaou A; Panagopoulou E; Gkoutzioulis M; Sympilidis G; Tarlatzis BC
    Arch Gynecol Obstet; 2016 Sep; 294(3):639-45. PubMed ID: 27086287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does subjective burden of early breast cancer and its treatment affect immune measures during adjuvant therapy?
    Sabbioni ME; Bernhard J; Siegrist HP; Schmitz SF; Gertsch MC; Thürlimann B; Bonnefoi H; Perey L; Herrmann R; Goldhirsch A; Hürny C;
    Breast Cancer Res Treat; 2004 Sep; 87(1):75-86. PubMed ID: 15377853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trial update: International Breast Cancer Study Group.
    Price KN; Goldhirsch A;
    Breast Cancer Res; 2005; 7(6):252-4. PubMed ID: 16280051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quality of life in elderly patients with localized breast cancer treated with radiotherapy. A prospective study.
    Arraras JI; Manterola A; Asin G; Illarramendi JJ; Cruz Sde L; Ibañez B; Delfrade J; Salgado E; Zarandona U; Cambra K; Vera R; Dominguez MA
    Breast; 2016 Apr; 26():46-53. PubMed ID: 27017241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a treatment gap during adjuvant chemotherapy in node-positive breast cancer: results of International Breast Cancer Study Group (IBCSG) Trials 13-93 and 14-93.
    ; Colleoni M; Gelber S; Simoncini E; Pagani O; Gelber RD; Price KN; Castiglione-Gertsch M; Coates AS; Goldhirsch A
    Ann Oncol; 2007 Jul; 18(7):1177-84. PubMed ID: 17429101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing the quality of life--a study in newly-diagnosed breast cancer patients.
    Ganz PA; Schag CA; Cheng HL
    J Clin Epidemiol; 1990; 43(1):75-86. PubMed ID: 2319284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Personalized adjuvant therapies: lessons from the past: the opening address by the St. Gallen 2013 award recipient.
    Goldhirsch A
    Breast; 2013 Aug; 22 Suppl 2():S3-7. PubMed ID: 24074788
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.
    Pagani O; Gelber S; Simoncini E; Castiglione-Gertsch M; Price KN; Gelber RD; Holmberg SB; Crivellari D; Collins J; Lindtner J; Thürlimann B; Fey MF; Murray E; Forbes JF; Coates AS; Goldhirsch A;
    Breast Cancer Res Treat; 2009 Aug; 116(3):491-500. PubMed ID: 18953651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic impact of amenorrhoea after adjuvant chemotherapy in premenopausal breast cancer patients with axillary node involvement: results of the International Breast Cancer Study Group (IBCSG) Trial VI.
    Pagani O; O'Neill A; Castiglione M; Gelber RD; Goldhirsch A; Rudenstam CM; Lindtner J; Collins J; Crivellari D; Coates A; Cavalli F; Thürlimann B; Simoncini E; Fey M; Price K; Senn HJ
    Eur J Cancer; 1998 Apr; 34(5):632-40. PubMed ID: 9713266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of quality of life scores in a trial of chemotherapy with or without interferon in patients with metastatic malignant melanoma.
    Coates A; Thomson D; McLeod GR; Hersey P; Gill PG; Olver IN; Kefford R; Lowenthal RM; Beadle G; Walpole E
    Eur J Cancer; 1993; 29A(12):1731-4. PubMed ID: 8398303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Impact of Age on Quality of Life in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Comparative Analysis From the Prospective Multicenter Randomized ADEBAR trial.
    Leinert E; Singer S; Janni W; Harbeck N; Weissenbacher T; Rack B; Augustin D; Wischnik A; Kiechle M; Ettl J; Fink V; Schwentner L; Eichler M
    Clin Breast Cancer; 2017 Apr; 17(2):100-106. PubMed ID: 27884722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group.
    Colleoni M; Bonetti M; Coates AS; Castiglione-Gertsch M; Gelber RD; Price K; Rudenstam CM; Lindtner J; Collins J; Thürlimann B; Holmberg S; Veronesi A; Marini G; Goldhirsch A
    J Clin Oncol; 2000 Feb; 18(3):584-90. PubMed ID: 10653873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjuvant chemotherapy in early breast cancer.
    Ejlertsen B
    Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
    Sharma R; Hamilton A; Beith J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004562. PubMed ID: 18843661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter?
    Bernhard J; Thürlimann B; Schmitz SF; Castiglione-Gertsch M; Cavalli F; Morant R; Fey MF; Bonnefoi H; Goldhirsch A; Hürny C
    J Clin Oncol; 1999 Jun; 17(6):1672-9. PubMed ID: 10561203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials.
    Bernhard J; Luo W; Ribi K; Colleoni M; Burstein HJ; Tondini C; Pinotti G; Spazzapan S; Ruhstaller T; Puglisi F; Pavesi L; Parmar V; Regan MM; Pagani O; Fleming GF; Francis PA; Price KN; Coates AS; Gelber RD; Goldhirsch A; Walley BA
    Lancet Oncol; 2015 Jul; 16(7):848-58. PubMed ID: 26092816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment.
    Glaus A; Boehme Ch; Thürlimann B; Ruhstaller T; Hsu Schmitz SF; Morant R; Senn HJ; von Moos R
    Ann Oncol; 2006 May; 17(5):801-6. PubMed ID: 16507565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.